Evolent Health (EVH) Operating Leases (2019 - 2026)

Evolent Health's Operating Leases history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Operating Leases fell 79.72% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 79.72% YoY), while the FY2025 annual figure was $3.8 million, down 84.71% from the prior year.
• Operating Leases was $3.2 million for Q1 2026 at Evolent Health, down from $3.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $65.0 million in Q2 2022 to a low of $3.2 million in Q1 2026.
• Historically, Operating Leases has averaged $37.5 million across 5 years, with a median of $38.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Operating Leases advanced 10.84% in 2022, then plunged 84.71% in 2025.
• A 5-year view of Operating Leases shows it stood at $56.0 million in 2022, then slumped by 32.14% to $38.0 million in 2023, then plunged by 34.31% to $25.0 million in 2024, then slumped by 84.71% to $3.8 million in 2025, then slipped by 17.23% to $3.2 million in 2026.
• The last three Operating Leases figures came in at $3.2 million (Q1 2026), $3.8 million (Q4 2025), and $22.4 million (Q3 2025), per Business Quant data.